BD Board Declares Dividend
BD (Becton, Dickinson and Company), a leading global medical technology company, has announced a quarterly dividend declaration by its Board of Directors. The dividend, set at $0.95 per common share, will be payable on September 30, 2024 to shareholders of record as of September 9, 2024. This dividend announcement indicates an annual dividend rate of $3.80 per share. The declaration demonstrates BD's commitment to providing regular returns to its shareholders, potentially reflecting the company's financial stability and confidence in its future performance.
BD (Becton, Dickinson and Company), un'importante azienda globale di tecnologia medica, ha annunciato la dichiarazione di un dividendo trimestrale da parte del suo Consiglio di Amministrazione. Il dividendo, fissato a 0,95 $ per azione ordinaria, sarà pagabile il 30 settembre 2024 agli azionisti registrati al 9 settembre 2024. Questo annuncio sul dividendo indica un tasso di dividendo annuo di 3,80 $ per azione. La dichiarazione dimostra l'impegno di BD a fornire ritorni regolari ai suoi azionisti, riflettendo potenzialmente la stabilità finanziaria dell'azienda e la fiducia nelle sue prestazioni future.
BD (Becton, Dickinson and Company), una empresa líder en tecnología médica a nivel global, ha anunciado la declaración de un dividendo trimestral por parte de su Junta Directiva. El dividendo, establecido en 0,95 $ por acción común, será pagadero el 30 de septiembre de 2024 a los accionistas registrados hasta el 9 de septiembre de 2024. Este anuncio de dividendo indica una tasa de dividendo anual de 3,80 $ por acción. La declaración demuestra el compromiso de BD de proporcionar retornos regulares a sus accionistas, lo que podría reflejar la estabilidad financiera de la empresa y la confianza en su rendimiento futuro.
BD (Becton, Dickinson and Company)는 세계적인 의료 기술 회사로, 이사회의 분기 배당금 선언을 발표했습니다. 배당금은 주당 0.95 달러로 설정되며, 2024년 9월 30일에 2024년 9월 9일 기준의 주주에게 지급될 예정입니다. 이 배당금 발표는 주당 연간 배당률 3.80 달러를 나타냅니다. 이번 선언은 BD가 주주에게 정기적인 수익을 제공하는 데 대한 의지를 보여주며, 회사의 재정적 안정성과 미래 성과에 대한 자신감을 반영할 수 있습니다.
BD (Becton, Dickinson and Company), une entreprise mondiale de technologie médicale, a annoncé une déclaration de dividende trimestriel par son conseil d'administration. Le dividende, fixé à 0,95 $ par action ordinaire, sera payable le 30 septembre 2024 aux actionnaires enregistrés au 9 septembre 2024. Cette annonce de dividende indique un taux de dividende annuel de 3,80 $ par action. La déclaration démontre l'engagement de BD à fournir des retours réguliers à ses actionnaires, reflétant potentiellement la stabilité financière de l'entreprise et la confiance dans ses performances futures.
BD (Becton, Dickinson and Company), ein führendes globales Medizintechnologieunternehmen, hat die Erklärung einer vierteljährlichen Dividende durch den Vorstand bekannt gegeben. Die Dividende, die auf 0,95 $ pro Stammaktie festgelegt wurde, wird am 30. September 2024 an die Aktionäre ausgezahlt, die am 9. September 2024 registriert sind. Diese Dividendenankündigung weist auf einen jährlichen Dividendenbetrag von 3,80 $ pro Aktie hin. Die Erklärung zeigt das Engagement von BD, den Aktionären regelmäßige Renditen bereitzustellen, was möglicherweise die finanzielle Stabilität des Unternehmens und das Vertrauen in seine zukünftige Leistung widerspiegelt.
- Quarterly dividend of $0.95 per common share declared
- Annual dividend rate of $3.80 per share indicated
- Consistent dividend payments suggest financial stability
- None.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-board-declares-dividend-302204458.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
What is the amount of BD's (BDX) quarterly dividend for September 2024?
When is the payment date for BD's (BDX) September 2024 dividend?
What is the record date for BD's (BDX) September 2024 dividend?
What is BD's (BDX) indicated annual dividend rate for 2024?
